HIGHLIGHTS
- who: Claus F. Vogelmeier from the Patients in Cohort , of DACCORD were recruited at , primary and secondary care practices distributed throughout Germany have published the Article: Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD u2018real worldu2019 study, in the Journal: (JOURNAL) of 17/01/2022
- what: The aim was analysed using a Cox regression analysis, with cohort as fixed factor. The overall aim of DACCORD Cohort 3 was to evaluate effectiveness and safety of a LABA/LAMA FDC (predominantly, although not exclusively, indacaterol/glycopyrronium) in patients with COPD who had . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.